Classement en actions
#15446
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops... BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Capitalisation boursière
$355.41M
Changement (1 jour)
-0.63%
Échange BioAge Labs Inc. (BIOA)
Le prix BIOA avec la capitalisation boursière de B
Capitalisation boursière de BioAge Labs Inc.(BIOA)
Capitalisation boursière: $355.41M
En September 2026, BioAge Labs Inc. a une capitalisation boursière de $355.41M. Cela fait de BioAge Labs Inc. la 15446th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de BioAge Labs Inc. du 2024 au 2026
BIOA par rapport au top 5 des plus populaires stocks
| Prix pour BIOA |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.327T
|
+1,498,666.31%
|
|
|
|
|
$4.645T
|
+1,306,797.13%
|
|
|
|
|
$4.070T
|
+1,145,121.34%
|
|
|
|
|
$3.785T
|
+1,064,741.47%
|
|
|
|
|
$2.790T
|
+784,937.80%
|
